PETALING JAYA: The import and sale of adrug used to treat women with abdominalpain and constipation associated with irritablebowel syndrome (IBS) has been suspendedwith immediate effect.
The medication Zelmac (tegaserod maleate),which is marketed in the United States underthe brand name Zelnorm, has been found bythe Food and Drug Administration (FDA) tocause a higher incidence of cardiovascularevents, according to a press statement by theHealth Ministry’s Drug Control Authority(DCA) yesterday.
Zelnorm was taken off the US market recently.The suspension would be in effect until furtherinformation was obtained, said the ministry’sdirector-general Tan Sri Dr Ismail Merican.
The statement also said that NovartisCorporation (M) Sdn Bhd, which has suspendedthe import and sale of Zelmac had advisedpatients being treated with the medication toseek alternative treatment for their condition.
Did you find this article insightful?